Lactulosa Lainco (Lactulose)

After oral intake, lactulose reaches the colon where gut bacteria break it down into lactic and acetic acids. The resulting acidification increases osmotic pressure, drawing water into the bowel to soften stool, and converts ammonia to ammonium, which is less readily absorbed, thereby lowering blood ammonia levels.

The appropriate dose of Lactulosa Lainco is individualized by the prescribing healthcare professional based on the patient’s condition, severity, age, renal function, and response to therapy. Dosage adjustments may be needed over time, and patients should follow the prescriber’s instructions precisely.

Safety data for lactulose in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare provider after a thorough risk‑benefit assessment.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lactulose is an osmotic laxative that works by increasing water content in the colon, whereas stimulant laxatives such as bisacodyl act by stimulating intestinal motility. Lactulose also uniquely lowers ammonia levels, a property not shared by most other laxatives, making it the preferred choice for hepatic encephalopathy.

Lactulosa Lainco should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain its stability and efficacy.

Lactulosa Lainco is taken orally, usually as a liquid or powder that is dissolved in water or another suitable beverage. It should be consumed according to the prescriber’s directions, typically with or without food, and the dose may be adjusted based on clinical response.

Serious risks, though uncommon, include severe electrolyte disturbances, dehydration, and allergic reactions such as rash or swelling. Patients experiencing persistent diarrhea, severe abdominal pain, or signs of an allergic response should seek medical attention promptly.

Lactulosa Lainco should be avoided in individuals with known hypersensitivity to lactulose, those with intestinal obstruction, perforation, or severe inflammatory bowel disease. Caution is also advised for patients with uncontrolled diabetes or significant renal impairment, and the decision should be made by a healthcare professional.